NONMEM Users Network Archive

Hosted by Cognigen

Modelling and Simulation Opportunities with Eisai

From: Mendel_Jansen
Date: Tue, 3 Apr 2007 14:29:43 +0100




Manager & Senior Manager, Clinical Pharmacology
Neg + Benefits, Hammersmith/Hatfield, UK

Eisai is recruiting two Modelling and Simulation specialists=
 to establish a
strong M&S group, within the Global Clinical Pharmacology =
function. The
M&S group?s focus is on bringing innovation and excellence=
 to drug
development.

With our excellent drug pipeline, in-licensing and the fur=
ther development
of marketed products - there is no better time to make=
 Eisai your next
career move.

Eisai is Japan?s fourth largest pharmaceutical company and =
is committed to
providing innovative healthcare for patients, their families =
and carers
around the world. Founded more than 60 years ago, it =
now operates a global
network of research facilities, manufacturing sites and mark=
eting
subsidiaries, and is a significant force in the worldwide =
pharmaceutical
industry, employing 8,000 people. Substantial inward invest=
ment in the UK
will create a new Strategic European Base in Hertfordshire=
 that will
underpin the company?s intention to expand business operatio=
ns across
Europe over the next five years and beyond.

You will be based in Hammersmith (London) or Hatfield (H=
ertfordshire),
within our European division of Eisai Global Clinical Deve=
lopment. You
will be part of a core team of four M&S experts head=
ed by the Associate
Director. You will work closely with other members of =
the Global Clinical
Pharmacology department from our London, New Jersey and To=
kyo operations.
Occasional travel will be required.

Senior Manager
In the Senior Manager role you will serve as the lead =
pharmacokineticist on
international project teams, contributing PK and M&S experti=
se at all
phases of the drug development process, from clinical intr=
oduction through
to registration. You will be responsible for the implem=
entation of M&S
strategies, including design and analysis of (population) PK=
 and PK/PD
studies, with the support of group members and through o=
utsourcing. You
will work closely with other members of the international =
project teams at
both strategic and operational level. As the M&S group =
is expanding, there
are also opportunities to focus the role in therapeutic =
areas and
development phases which fit with your individual expertise =
and interests.

You will be an astute pharmacokineticist with demonstrable, =
hands-on
experience in population PK/PD, Modelling and Simulation, us=
ing NONMEM and
S-Plus / R. You will have a relevant PhD or equival=
ent experience and a
science degree. Experience of working in the pharmaceutic=
al industry is a
definite advantage. You will be proactive with excellent =
communication,
organizational and mentoring skills are excellent.

Manager
In the Manager role you will concentrate on conducting a=
nalyses, from
simple NCA to more complex (semi) physiological and drug/d=
isease M&S. You
will support senior group members in the M&S and wider =
clinical
pharmacology groups, and also benefit from their friendly =
support and
mentoring. Outside the group you will interact with cli=
nical, data
management and biostatistics staff.

You will be a graduate in a relevant scientific / math=
ematical discipline
and have a good knowledge of PK and PK/PD. As a m=
inimum you will have a
basic understanding of the population approach. Experience =
with NONMEM is
an advantage and training and mentoring will be available =
to develop
further expertise in M&S. You will be genuinely interes=
ted in the
application of PK/PD and M&S in drug development and wil=
ling to learn. You
will have good attention to detail, and work well both =
individually and in
a team. Experience working in the pharmaceutical industry=
 is an advantage.


For your next career move please send your CV and a =
covering letter,
highlighting relevant experience and current earnings details =
to:
response

www.eisai.co.uk

THIS EMAIL AND ANY ATTACHED FILES ARE CONFIDENTIAL.
If you are not the intended recipient you are notified =
that any disclosure, reproduction,copying, distribution, or =
action taken in reliance on the contents of this info=
rmation is strictly prohibited. If you have received =
this transmission in error please notify the sender immedi=
ately and then delete this email. Email transmission ca=
nnot be guaranteed to be secure or error free as infor=
mation could be intercepted, corrupted, lost, destroyed,arrive=
 late or incomplete, or contain viruses. The company/sende=
r accepts no liability for any changes made to this =
email during transmission or any damage caused by any =
virus transmitted by this email. Any views or opinions =
expressed in this email are solely those of the author =
and do not necessarily represent those of the company. T=
he company/sender accepts no liability for the content =
of this email, or for the consequences of any actions =
taken on the basis of the information provided, unless t=
hat information is subsequently confirmed in writing.
Received on Tue Apr 03 2007 - 09:29:43 EDT

The NONMEM Users Network is maintained by ICON plc. Requests to subscribe to the network should be sent to: nmusers-request@iconplc.com.

Once subscribed, you may contribute to the discussion by emailing: nmusers@globomaxnm.com.